In our study, SERPIN-G1, a serine protease inhibitor preventing spontaneous activation of the complement system, was also upregulated in patients with psoriasis potentially moderating the damaging effects of increased levels of circulating complement factors. This evidence concerns the gene SERPING1 and psoriasis.